Supply Chain Intelligence

Arvinas, Inc. Supply Chain

ARVN supply chain intelligence for Arvinas, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ARVN ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
3Customers
3Debt Items
20Related Chains

Arvinas, Inc. Suppliers

TickerNameConfidenceEvidence
PFE Pfizer Inc. 92% In July 2021, Arvinas announced a global collaboration with Pfizer for the co-development and co-commercialization of vepdegestrant; Arvinas and Pfizer will share worldwide development costs, commerc…
PFE Pfizer Inc. 92% Reciprocal relationship from PFE graph: Reciprocal relationship from ARVN graph: Reciprocal relationship from PFE graph: Reciprocal relationship from ARVN graph: In July 2021, Arvinas announced a glo…

Arvinas, Inc. Customers

TickerNameConfidenceEvidence
PFE Pfizer Inc. 90% Revenue for the quarter is related to the Vepdegestrant (ARV-471) Collaboration Agreement with Pfizer and the collaboration and license agreement with Pfizer.
PFE Pfizer Inc. 90% Reciprocal relationship from PFE graph: Reciprocal relationship from ARVN graph: Revenue for the quarter is related to the Vepdegestrant (ARV-471) Collaboration Agreement with Pfizer and the collabor…
RIGEL-PHARMACEUTICALS-INC RIGEL-PHARMACEUTICALS-INC 85% Entered into a license agreement with Rigel Pharmaceuticals, Inc. for the for the exclusive global development, manufacturing, and commercialization rights for VEPPANU.

Arvinas, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ARVN-DEBT-7863 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.
ARVN-DEBT-7862 Warrants outstanding: 0.001 90% xbrl warrant detail from xbrl 2023-12-31.
ARVN-DEBT Debt stack $8.4M 90% Market cache reports total debt of $8.4M.

Arvinas, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Arvinas, Inc..

Arvinas, Inc. Ownership

HolderNameConfidenceEvidence
ARVN-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 208 tracked holders.

Arvinas, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
PFE Pfizer Inc. 60.75 1 ['customer', 'supplier']
PFIZER PFIZER 60.75 1 ['receiving']
ORANY ORANGE 50.00 2
PLX Protalix BioTherapeutics, Inc. 50.00 2
CELG-RI BRISTOL MYERS SQUIBB CO 50.00 2
RLAY Relay Therapeutics, Inc. 50.00 2
SPRO Spero Therapeutics, Inc. 50.00 2
HBIO Harvard Bioscience, Inc. 50.00 2
NVAX Novavax, Inc. 50.00 2
NRIX Nurix Therapeutics, Inc. 50.00 2
ZNTL Zentalis Pharmaceuticals, Inc. 50.00 2
ALLO Allogene Therapeutics, Inc. 37.71 2
CCCC C4 Therapeutics, Inc. 37.71 2
ITRM Iterum Therapeutics PLC 37.71 2
CELC Celcuity Inc. 37.71 2
PYXS Pyxis Oncology, Inc. 37.71 2
AURX Nuo Therapeutics, Inc. 36.09 2
ESPR Esperion Therapeutics, Inc. 36.09 2
ZURA Zura Bio Limited 36.09 2
CAH Cardinal Health, Inc. 23.09 2
View ARVN supply chain intel →

Explore the full interactive supply chain map for Arvinas, Inc..

Open ARVN supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map